INS and Hypoglycemia: Insulin is osteoanabolic, through direct activation of osteoblasts, sparking debate as to whether this increased fracture risk is a direct result of exogenous insulin on bone or whether there are indirect effects, such as hypoglycemia-induced falls or increased fall impact due to weight gain from insulin therapy [20].